Skip to content
Screener

NeoGenomics NEO Interest Income

Interest Income at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$700K+133%
Labcorp Holdings logo
Labcorp HoldingsLH
$5.6M+229%
Personalis, Inc. logo
Personalis, Inc.PSNL
$2.17M+7.2%
Guardant Health logo
Guardant HealthGH
$11.15M+22.4%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$8.65M+7.9%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$3.9M+257%

Segments

By segment

See full
Reportable Segment$1.21M-46.4%

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2.13B+183%
Enterprise value$2.43B+264%
P/S2.8×+1.7×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Impairment charges (Note 5)20,04120,041
Total operating expenses101,649124,886200,754225,957
LOSS FROM OPERATIONS(9,771)(47,628)(28,012)(75,453)
Interest income1,2142,2632,4875,984
Interest expense(781)(933)(1,379)(2,551)
Other (expense) income, net(17)482(29)547
Gain on extinguishment of debt (Note 6)11,18111,181
Income (loss) before taxes1,826(45,816)(15,752)(71,473)

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's interest income?
NeoGenomics (NEO) reported interest income of $1.21M in Q2 2026.
How has NeoGenomics's interest income changed year-over-year?
NeoGenomics's interest income decreased by 46.4% year-over-year, from $2.26M to $1.21M.
What is the long-term trend for NeoGenomics's interest income?
Over 3 years (2022 to 2025), NeoGenomics's interest income has grown at a 14.3% compound annual growth rate (CAGR), from $6.08M to $9.07M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about NeoGenomics's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude